SCHEMBL23047302

SCHEMBL23047302

CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(NSC5CC5)cc4)c4c(N)ncnc43)cc2)no1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 19/20 0.68
▸ LCK P06239 1/20 0.68
▸ CSF1R P07333 1/20 0.68
▸ RET P07949 1/20 0.68
▸ PDGFRB P09619 1/20 0.68
▸ KIT P10721 1/20 0.68
▸ PDGFRA P16234 1/20 0.68
▸ CDK11B P21127 1/20 0.68
▸ CCNC P24863 1/20 0.68
▸ FLT4 P35916 1/20 0.68
▸ CDK8 P49336 1/20 0.68
▸ BTK Q06187 1/20 0.68
▸ DDR1 Q08345 1/20 0.68
▸ DDR2 Q16832 1/20 0.68
▸ MKNK2 Q9HBH9 1/20 0.68
▸ RIPK1 Q13546 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19683595 0.88 FLT3 (0.70) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683864 0.88 FLT3 (0.69) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683649 0.88 FLT3 (0.68) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683593 0.88 FLT3 (0.69) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683746 0.87 FLT3 (0.80) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683645 0.87 FLT3 (0.69) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683707 0.87 FLT3 (0.65) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683869 0.87 FLT3 (0.69) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683614 0.87 FLT3 (0.74) FLT3LCKCSF1RRETPDGFRB
SCHEMBL19683620 0.86 FLT3 (0.68) FLT3LCKCSF1RRETPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466952-B1 1-(4-(4-AMINO-3-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)-PHENYL)-UREA DERIVATIVES AS FLT3 KINASE INHIBITORS FOR TREATING CANCER PRECEDO PHARMACEUTICALS CO LTD (CN) 2021-03-03 — — EP disclosed
Send feedback